UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049228
Receipt number R000055934
Scientific Title Serum leucine-rich alpha-2 glycoprotein levels for predicting ultrasonographic findings in intestinal lesion of patients with Crohn's disease in clinical remission (SAPICL study)
Date of disclosure of the study information 2022/10/17
Last modified on 2022/11/13 09:48:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Serum leucine-rich alpha-2 glycoprotein levels for predicting ultrasonographic findings in intestinal lesion of patients with Crohn's disease in clinical remission (SAPICL study)

Acronym

SAPICL study

Scientific Title

Serum leucine-rich alpha-2 glycoprotein levels for predicting ultrasonographic findings in intestinal lesion of patients with Crohn's disease in clinical remission (SAPICL study)

Scientific Title:Acronym

SAPICL study

Region

Japan


Condition

Condition

Crohn's disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyze the relationship between the severity of intestinal ultrasonographic findings and leucine-rich alpha-2 glycoprotein (LRG) levels for Crohn's disease in clinical remission.

Basic objectives2

Others

Basic objectives -Others

To evaluate the LRG cutoff value for predicting the activity of intestinal ultrasonographic parameters.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Determining the cutoff value of LRG levels for predicting positive bowel wall thickness (BWT), focally or extensively disrupted bowel wall echo patterns, and respective superb micro-vascular imaging(SMI) grades and calculating the sensitivity and specificity.

Key secondary outcomes

Comparison of the median LRG levels for the positive BWT, focally or extensively disrupted bowel wall echo patterns, and respective SMI grades.
Proportion of patients with positive BWT, those with focally or extensively disrupted bowel wall echo pattern, and those with respective SMI grades, respectively stratified by cutoff value of LRG levels.
Proportion of patients with focally or extensively disrupted bowel wall echo pattern and that with respective SMI grades, respectively stratified by BWT.
Evaluating the background factors related to the LRG levels.
Determining the LRG cutoff value stratified by the background factors related to LRG levels and calculating the sensitivity and specificity.
Etc


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

CD patients of all ages who had evaluated LRG levels and received intestinal ultrasonography on the same day between September 2020 and August 2022.In case that LRG measurement and intestinal ultrasonography were performed multiple times within the applicable period, the first time of the investigation were recruited.

Key exclusion criteria

(1) Patients whose data of Harvey-Bradshaw Index (HBI) could not be evaluated from medical records.
(2) Patients whose HBI is 5 or above.
(3) Patients who had underwent intestinal resection.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hiroki
Middle name
Last name Tanaka

Organization

Sapporo IBD Clinic

Division name

N/A

Zip code

064-0919

Address

Yamahana Doctor Town F2, 1-18, Minami-19, Nishi-8, Chuo-ku, Sapporo, HOKKAIDO, 064-0919, JAPAN

TEL

011-213-0397

Email

hirokit@mtc.biglobe.ne.jp


Public contact

Name of contact person

1st name Hiroki
Middle name
Last name Tanaka

Organization

Sapporo IBD Clinic

Division name

N/A

Zip code

064-0919

Address

Yamahana Doctor Town F2, 1-18, Minami-19, Nishi-8, Chuo-ku, Sapporo, HOKKAIDO, 064-0919, JAPAN

TEL

011-213-0397

Homepage URL


Email

hirokit@mtc.biglobe.ne.jp


Sponsor or person

Institute

Sapporo IBD Clinic

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo IBD Clinic

Address

Yamahana Doctor Town F2, 1-18, Minami-19, Nishi-8, Chuo-ku, Sapporo, HOKKAIDO, 064-0919, JAPAN

Tel

011-213-0397

Email

hirokit@mtc.biglobe.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 10 Month 14 Day

Date of IRB

2022 Year 10 Month 18 Day

Anticipated trial start date

2022 Year 10 Month 18 Day

Last follow-up date

2025 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study


Management information

Registered date

2022 Year 10 Month 16 Day

Last modified on

2022 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055934


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name